TransMedics (TMDX) Net Shares Issued and Repurchased (2019 - 2026)

TransMedics has reported Net Shares Issued and Repurchased for 8 years, with the latest figure at $40089.0 in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 86.02% year-over-year to $40089.0 in Q1 2026; TTM through Mar 2026 was $40089.0, a 86.02% decrease from a year earlier, with the FY2025 full-year figure at $352045.0, down 7.31% from the prior year.
• Net Shares Issued and Repurchased was $40089.0 for Q1 2026 at TransMedics, down from $352045.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $1.2 million in Q4 2022, with the low at $40089.0 in Q1 2026.
• Average Net Shares Issued and Repurchased over 5 years is $489587.3, with a median of $352045.0 recorded in 2025.
• The sharpest annual moves came in 2022 and 2026: Net Shares Issued and Repurchased climbed 10.95% in 2022, then sank 86.02% in 2026.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.2 million in 2022, then sank by 46.56% to $639045.0 in 2023, then tumbled by 40.56% to $379828.0 in 2024, then declined by 7.31% to $352045.0 in 2025, then sank by 88.61% to $40089.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $40089.0 (Q1 2026), $352045.0 (Q4 2025), and $286732.0 (Q1 2025), per Business Quant data.